Recently, "Yolkin," the consumer probiotics brand under Xbiome, collaborated with "Sun Beibei," a star brand specializing in healthy baking, to launch three standout products: Blueberry Probiotic Cream-Filled Puff Pastry, Blueberry Probiotic Raw Sweet Donut, and Blueberry Probiotic Cream-Filled Croissant with Real Fruit. These three new products are specially formulated with Xbiome's patented weight-management star strain XA-1416, meeting consumers' advanced demands for "low-burden, ultra-light" healthy baked goods.
Sun Beibei's team stated that blueberries, known as the "king of berries," are rich in natural anthocyanins and vitamin C, low in sugar and fat, and have a sweet-and-sour taste that cuts through richness. They are one of the fastest-growing fruit flavor segments in the industry. Data shows that the blueberry flavor consistently ranks among the top three popular fruit flavors in baking, showing strong growth momentum. Behind the rising popularity of the blueberry flavor lies consumers' all-around demand for product health attributes, taste experience, and scenario compatibility. "Low burden, high nutrition, and high aesthetic appeal" have become the core dimensions of industry competition.
In response to this, Sun Beibei, Yang Le Jun, and Xbiome have closely followed industry trends to create a new blueberry series. Centered on "active probiotics + natural blueberries + low-sugar formula" and empowered by the scientific capabilities of XA-1416, it precisely meets the demands of today's consumers. Leveraging Sun Beibei’s world-class baking R&D expertise, in collaboration with the top research teams from Yang Le Jun and Xbiome, three core products have been launched. These products build differentiated competitiveness across four dimensions—ingredients, formulation, taste, and usage scenarios—delivering a balance of health and deliciousness to consumers.
XA-1416, hailed by Xinhua News Agency as a representative of "China's Bacteria," is a star strain from Xbiome. It has obtained a national invention patent in the field of fat reduction and weight loss (Patent No.: 2024105421782) and is preserved at the Institute of Microbiology, Chinese Academy of Sciences (CGMCC No. 40307). Relevant research findings were recently officially published in Gut Microbes (Impact Factor 15.2, CAS Double First-Class Journal), the top journal in the global gut microbiota field. XA-1416 originates from the gut of healthy Asian populations and is produced through AI high-throughput screening and a patented freeze-drying process. It is resistant to gastric acid and bile salts, with a survival rate exceeding 97%, and can help reduce fat absorption and regulate gut microbiota in the human body.
The XA-1416 strain, paired with Sun Beibei Bread's low-sugar formula, scientifically achieves "low burden, ultra-lightness," meeting consumers' demand for healthy baking, allowing individuals sensitive to body fat and weight to enjoy it with peace of mind. Additionally, in terms of ingredient selection, Sun Beibei adheres to the principle of "high quality, naturalization." The blueberry ingredients are sourced from premium blueberries in Liaoning and floral-scented blueberries from Yunnan, with fruit content exceeding 60%. It strictly maintains 0 preservatives, 0 trans fats, and uses 100% animal cream, further providing consumers with a natural and healthy baking experience.
The launch of the three star products highlights Sun Beibei's precise insight and keen layout regarding the health-oriented, functional, and scenario-based trends in the baking industry. It also demonstrates Xbiome's significant momentum in empowering traditional food and beverage industry partners with patented functional strains. Both parties look forward to deepening cooperation to provide a referable and replicable new path for the health-focused and quality upgrade of the baking industry, seizing the high ground in the healthy baking and fruit flavor sectors through differentiated innovation.
Note: The above content does not involve product efficacy promotion. It only cites publicly published academic reports and patent application materials as an introduction to the strain.
-End-